Oracle Health Helps San Juan Regional Improve Patient Flow
Austin, Texas, U.S., September 18, 2026 Oracle Health and San Juan Regional Medical Center have expanded their collaboration to...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Austin, Texas, U.S., September 18, 2026 Oracle Health and San Juan Regional Medical Center have expanded their collaboration to...
Oslo, Norway, August 14, 2026 Photocure ASA has welcomed a new proposal from the U.S. Food and Drug Administration...
New York, New York, August 13, 2026 Aidoc announced that its CAREâ„¢ Body CT Multi-Triage has received eligibility for...
BOCA RATON, Fla., June 2026 SurGenTec® has announced U.S. FDA clearance for its ION-L™ Lumbar Facet Fixation System, a...
PALO ALTO, Calif., May 14, 2026 Glooko, Inc. announced that the U.S. Food and Drug Administration has granted 510(k)...
